Alphabet’s biolab in funding talks at $40B valuation
FROM THE PUBLISHER
Alphabet’s Isomorphic Labs is reportedly in fundraising talks at a $40 billion valuation , the latest sign of strong investor appetite for AI despite growing fears of a bubble. The company — led by Nobel Prize winner and former Google DeepMind CEO Demis Hassabis — hopes the new investment will accelerate its push to develop new drugs. Firms including China’s DeepSeek and Moonshot, as well as industry giant OpenAI, are also chasing billions in fresh…
Original reporting by Semafor. Some articles may require a subscription.